Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mohs

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Missouri Medicine|December 1, 1994
New documentation guidelines for evaluation and management servicesF R Mohs
Missouri Medicine|June 25, 1998
The Carrier Advisory Committee five years laterF R Mohs
Missouri Medicine|February 4, 1998
Evaluation and management services, new documentation guidelinesF R Mohs
Archives of Neurology|March 1, 1991
Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measuresK Welsh, N Butters, J Hughes, et al.
Lancet (London, England)|May 17, 1997
Apolipoprotein E genotype and cognition in the very oldL D Altstiel, D A Greenberg, D Marin, et al.
Journal of Gerontology|July 1, 1993
Cognitive performance in a high-functioning community-dwelling elderly populationS K Inouye, M S Albert, R Mohs, et al.
Journal of Molecular Neuroscience : MN|May 10, 2001
Correlation of the clinical severity of Alzheimer's disease with an aberration in mitochondrial DNA (mtDNA)A M Brown, R K Sheu, R Mohs, et al.
Neurology|January 27, 1998
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study GroupS L Rogers, M R Farlow, R S Doody, et al.
Neurology|August 1, 1995
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XI. Clinical milestones in patients with Alzheimer's disease followed over 3 yearsD Galasko, S D Edland, J C Morris, et al.
Neurology|January 1, 1996
Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease: A CERAD analysis, Part XIIE Koss, S Edland, G Fillenbaum, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Missouri Medicine|December 1, 1994
New documentation guidelines for evaluation and management servicesF R Mohs
Missouri Medicine|June 25, 1998
The Carrier Advisory Committee five years laterF R Mohs
Missouri Medicine|February 4, 1998
Evaluation and management services, new documentation guidelinesF R Mohs
Archives of Neurology|March 1, 1991
Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measuresK Welsh, N Butters, J Hughes, et al.
Lancet (London, England)|May 17, 1997
Apolipoprotein E genotype and cognition in the very oldL D Altstiel, D A Greenberg, D Marin, et al.
Journal of Gerontology|July 1, 1993
Cognitive performance in a high-functioning community-dwelling elderly populationS K Inouye, M S Albert, R Mohs, et al.
Journal of Molecular Neuroscience : MN|May 10, 2001
Correlation of the clinical severity of Alzheimer's disease with an aberration in mitochondrial DNA (mtDNA)A M Brown, R K Sheu, R Mohs, et al.
Neurology|January 27, 1998
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study GroupS L Rogers, M R Farlow, R S Doody, et al.
Neurology|August 1, 1995
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XI. Clinical milestones in patients with Alzheimer's disease followed over 3 yearsD Galasko, S D Edland, J C Morris, et al.
Neurology|January 1, 1996
Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease: A CERAD analysis, Part XIIE Koss, S Edland, G Fillenbaum, et al.
Pageof 3